| Literature DB >> 29695271 |
Luis Eduardo Ferreira1, Bruno Iglesias Benincasa1, Ana Lúcia Fachin1, Silvia Helena Taleb Contini1, Suzelei Castro França1, Ana Carolina Souza Chagas2, Rene Oliveira Beleboni3.
Abstract
BACKGROUND: Infections of sheep with gastrointestinal parasites, especially Haemonchus contortus, have caused serious losses in livestock production, particularly after the emergence of resistance to conventional anthelmintics. The search for new anthelmintic agents, especially those of botanical origin, has grown substantially due to the perspective of less contamination of meat and milk, as well as other advantages related to their cost and accessibility in less developed countries. The aim of this study was to evaluate the in vitro anthelmintic activity of essential oils of the plant species Citrus aurantifolia, Anthemis nobile and Lavandula officinalis against the main developmental stages of the parasite H. contortus.Entities:
Keywords: Botanical anthelmintics; Gastrointestinal nematodes; In vitro assays; Plants; Small ruminants
Mesh:
Substances:
Year: 2018 PMID: 29695271 PMCID: PMC5918559 DOI: 10.1186/s13071-018-2849-x
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Relative percentage (%) of compounds from essential oils determined by CG-MS
| RI | Component |
|
|
|
|---|---|---|---|---|
| 914 | Amyl acetate | – | 0.10 | – |
| 1062 | Artemisia ketona | – | 5.84 | – |
| 1505 | β-Bisabolene | 0.89 | – | – |
| 1169 | Borneol | – | 0.18 | 2.14 |
| 811 | Butyl acetate | – | 1.11 | 0.80 |
| 954 | Camphene | – | 0.52 | 0.18 |
| 1146 | Camphor | – | – | 5.54 |
| 1419 | (E)-Caryophyllene | – | – | 2.37 |
| 1031 | 1.8-Cineole | – | 3.97 | 4.87 |
| 952 | Cyclohexanone <3-methyl-> | – | 0.62 | – |
| 1024 | ρ-Cymene | 4.17 | – | – |
| 804 | Ethyl butanoate | – | 0.41 | 4.08 |
| 990 | Furfuryl acetate | – | 0.61 | – |
| 1101 | Hexyl propanoate | – | 0.25 | – |
| 1146 | Isoamyl angelate | – | 15.27 | – |
| 1009 | Isoamyl isobutyrate | – | 2.73 | – |
| 1160 | Isoborneol | – | – | 0.30 |
| 1051 | Isobutyl angelate | – | 29.26 | – |
| 911 | Isobutyl isobutyrate | – | 3.93 | – |
| 1090 | Isobutyl tiglate | – | 0.71 | – |
| 876 | Isopentyl acetate | – | – | 0.42 |
| 1290 | Lavandulyl acetate | – | – | 0.77 |
| 1029 | Limonene | 56.37 | – | 0.52 |
| 1257 | Linalool acetate | – | – | 35.97 |
| 1088 | ρ-Mentha-2,4(8)-diene | – | – | 0.24 |
| 988 | Myrcene | 0.67 | – | 0.16 |
| 1195 | Myrtenol | – | 0.77 | – |
| 1050 | (E)-β-Ocimene | – | – | 0.74 |
| 1037 | (Z)-β-Ocimene | – | – | 0.56 |
| 1132 | Allo-Ocimene | – | – | 0.61 |
| 991 | 3-Octanol | – | 0.56 | – |
| 1055 | Pentyl isobutanoate | – | 0.53 | – |
| 979 | β-Pinene | 11.86 | – | – |
| 1170 | Pinocampheol | – | – | 0.31 |
| 1175 | Cis-Pinocamphone | – | 0.37 | – |
| 1164 | Pinocarvone | – | 3.15 | – |
| 975 | Sabinene | – | 6.27 | 0.22 |
| 1098 | Trans-Sabinene hydrate | – | – | 29.17 |
| 1221 | Cis-Sabinene hydrate acetate | – | – | 0.14 |
| 1142 | Trans-Sabinol | – | 4.47 | – |
| 1177 | 4-ol-Terpinen | – | – | 0.74 |
| 1059 | γ-Terpinene | 11.42 | – | – |
| 1199 | γ-Terpineol | – | – | 0.85 |
| 930 | α-Thujene | 2.85 | 8.92 | 0.31 |
| 1431 | Cis-Thujopsene | 1.20 | – | – |
| 967 | Verbenene | 1.74 | – | – |
| Not identifield | 8.83 | 9.46 | 8.01 | |
| Total analyzed | 91.17 | 90.54 | 91.99 |
Abbreviation: RI, retention index
Effects (mean percentage ± SE) of tested essential oils on inhibition of egg hatching of H. contortus
| Concentration (mg/ml) |
|
|
|
|---|---|---|---|
| 50 | 100.0 ± 0.0a,b | 99.0 ± 0.38a,b | 100.0 ± 0.0a,b |
| 25 | 100.0 ± 0.0a,b | 99.4 ± 0.87a,b | 100.0 ± 0.0a,b |
| 12.5 | 98.9 ± 1.87a,b | 97.0 ± 2.38a,b | 99.8 ± 0.30a,b |
| 6.25 | 96.4 ± 2.61a,b | 95.7 ± 2.13a,b | 99.4 ± 0.94a,b |
| 3.125 | 95.9 ± 2.41a,b | 86.4 ± 4.71b | 92.3 ± 3.03b |
| 1.562 | 86.9 ± 2.33b | 74.5 ± 3.58b | 82.8 ± 3.62b |
| 0.781 | 56.2 ± 3.97b | 63.3 ± 4.12b | 85.0 ± 3.15b |
| 0.390 | 42.1 ± 4.70b | 26.6 ± 1.46b | 81.8 ± 1.36b |
| 0.195 | 14.9 ± 3.89b | 13.4 ± 2.33b | 9.5 ± 1.54b |
| 0.097 | 13.0 ± 1.44b | 14.1 ± 2.60b | 6.8 ± 1.69 |
| IC50 = 0.694 mg/ml | IC50 = 0.842 mg/ml | IC50 = 0.316 mg/ml | |
| Thiabendazol (0.025 mg/ml) | 100.0 ± 0.0b | 100.0 ± 0.0b | 100.0 ± 0.0b |
| Tween 80 (3%) | 7.6 ± 0.85 | 7.4 ± 3.94 | 3.5 ± 0.82 |
Abbreviations: IC50, inhibitory concentration 50%; R2, nonlinear correlation coefficient
aNo statistically significant difference between positive control and treatments
bSignificant difference between positive control or treatments with negative control (ANOVA, followed by Tukey test; P < 0.05)
Effects (mean percentage ± SE) of different concentrations of essential oils on inhibition of larval development of H. contortus
| Concentration (mg/ml) |
|
|
|
|---|---|---|---|
| 3.0 | – | 100.0 ± 0.0a,b | 95.3 ± 1.84a,b |
| 1.5 | 100.0 ± 0.0a,b | 100.0 ± 0.0a,b | 89.8 ± 0.88b |
| 0.75 | 100.0 ± 0.0a,b | 97.2 ± 2.26a,b | 81.4 ± 1.83b |
| 0.375 | 90.1 ± 1.68b | 86.4 ± 2.34b | 64.2 ± 1.79b |
| 0.187 | 85.4 ± 2.62b | 67.1 ± 3.26b | 35.9 ± 0.98b |
| 0.0937 | 71.5 ± 1.35b | 46.9 ± 1.18b | 11.5 ± 0.95 |
| 0.0468 | 61.8 ± 1.16b | 31.3 ± 2.81b | 12.0 ± 2.83 |
| 0.0234 | 41.2 ± 0.81b | 27.4 ± 1.61b | 9.9 ± 2.02 |
| 0.0117 | 14.7 ± 1.81b | 20.5 ± 1.28b | 8.8 ± 1.44 |
| 0.0058 | 10.8 ± 0.35 | 12.4 ± 1.17 | 6.3 ± 0.64 |
| 0.0029 | 9.1 ± 0.59 | – | – |
| IC50 = 0.044 mg/ml | IC50 = 0.117 mg/ml | IC50 = 0.280 mg/ml | |
| Levamisol (20 mg/ml) | 99.8 ± 0.21b | 99.8 ± 0.21b | 99.8 ± 0.21b |
| DMSO (1%) | 9.3 ± 2.16 | 7.8 ± 0.72 | 7.5 ± 3.17 |
Abbreviations:C50, inhibitory concentration 50%; R2, nonlinear correlation
aNo statistically significant difference between positive control and treatments
bSignificant difference between positive control or treatments with negative control (ANOVA, followed by Tukey test; P < 0.05)
Percentage of motility of H. contortus adult worns when exposed to different concentrations of essential oils
| Time (hours) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (mg/ml) | 0 | 2 | 4 | 6 | 8 | 10 | 12 | 14 | 16 | 18 | 20 | 22 | 24 | |
| Control (+) | – | 100 | 49b | 22b | 9b | 2b | 0b | 0b | 0b | 0b | 0b | 0b | 0b | 0 |
| Control (-) 1 | – | 100a | 100 | 91 | 84 | 71 | 53 | 40 | 31 | 22 | 16 | 11 | 7 | 0a |
| Control (-) 2 | – | 100a | 100 | 91 | 80 | 64 | 51 | 33 | 24 | 18 | 13 | 4 | 2 | 0a |
|
| 50.0 | 100a | 49a,b | 27a,b | 11a,b | 7a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a |
| 5.0 | 100a | 49a,b | 27a,b | 18a,b | 9a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
| 0.5 | 100a | 87b | 58b | 40b | 13b | 9b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
|
| 50.0 | 100a | 44a,b | 13a,b | 4a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a |
| 5.0 | 100a | 49a,b | 18a,b | 13a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
| 0.5 | 100a | 69b | 38b | 33b | 16b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
|
| 50.0 | 100a | 44a,b | 31a,b | 13a,b | 7a,b | 0a,b | 0a | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a |
| 5.0 | 100a | 56a,b | 36b | 29b | 1 a,b | 2a,b | 0a | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
| 0.5 | 100a | 82b | 54b | 44b | 24b | 13b | 9a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a,b | 0a | |
Key: Control (+), levamisole 20 mg/ml; Control (-) 1, PBS + antibiotic (penicillin/streptomycin) 4% + tween 80 2%; Control (-) 2, PBS + antibiotic (penicillin/streptomycin) 4%
aNo statistically significant difference between positive control and treatments
bSignificant difference between positive control or treatments with negative control (ANOVA, followed by Tukey test; P < 0.05)